Publications

  1. Tobin WO, Lennon VA, Komorowski L, Probst C, Clardy SL, Aksamit AJ, Appendino JP, Lucchinetti CF, Matsumoto JY, Pittock SJ, Sandroni P, Tippmann-Peikert M, Wirrell EC, McKeon A. DPPX potassium channel antibody: Frequency, clinical accompaniments, and outcomes in 20 patients. Neurology. 2014 Nov 11; 83(20):1797-803. Epub 2014 Oct 15.
    View PubMed
  2. Chopra A, Abulseoud OA, Sampson S, Lee KH, Klassen BT, Fields JA, Matsumoto JY, Adams AC, Stoppel CJ, Geske JR, Frye MA. Mood Stability in Parkinson Disease Following Deep Brain Stimulation: A 6-Month Prospective Follow-up Study. Psychosomatics. 2014 Sep-Oct; 55(5):478-84. Epub 2013 Dec 21.
    View PubMed
  3. Kucewicz MT, Cimbalnik J, Matsumoto JY, Brinkmann BH, Bower MR, Vasoli V, Sulc V, Meyer F, Marsh WR, Stead SM, Worrell GA. High frequency oscillations are associated with cognitive processing in human recognition memory. Brain. 2014 Aug; 137(Pt 8):2231-44. Epub 2014 Jun 11.
    View PubMed
  4. Clardy SL, Lennon VA, Dalmau J, Pittock SJ, Jones HR Jr, Renaud DL, Harper CM Jr, Matsumoto JY, McKeon A. Childhood onset of stiff-man syndrome. JAMA Neurol. 2013 Dec; 70(12):1531-6.
    View PubMed
  5. Kasasbeh A, Abulseoud OA, Matsumoto JY, Stead SM, Goerss SJ, Klassen BT, Huston J 3rd, Min HK, Lee KH, Frye MA. Lack of differential motor outcome with subthalamic nucleus region stimulation in Parkinson's disease. J Clin Neurosci. 2013 Nov; 20(11):1520-6. Epub 2013 Jul 29.
    View PubMed
  6. Matsumoto A, Brinkmann BH, Matthew Stead S, Matsumoto J, Kucewicz MT, Marsh WR, Meyer F, Worrell G. Pathological and physiological high-frequency oscillations in focal human epilepsy. J Neurophysiol. 2013 Oct; 110(8):1958-64. Epub 2013 Aug 07.
    View PubMed
  7. Matsumoto JY, Stead M, Kucewicz MT, Matsumoto AJ, Peters PA, Brinkmann BH, Danstrom JC, Goerss SJ, Marsh WR, Meyer FB, Worrell GA. Network oscillations modulate interictal epileptiform spike rate during human memory. Brain. 2013 Aug; 136(Pt 8):2444-56. Epub 2013 Jun 25.
    View PubMed
  8. O'Toole O, Lennon VA, Ahlskog JE, Matsumoto JY, Pittock SJ, Bower J, Fealey R, Lachance DH, McKeon A. Autoimmune chorea in adults. Neurology. 2013 Mar 19; 80(12):1133-44. Epub 2013 Feb 20.
    View PubMed
  9. McKeon A, Martinez-Hernandez E, Lancaster E, Matsumoto JY, Harvey RJ, McEvoy KM, Pittock SJ, Lennon VA, Dalmau J. Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol. 2013 Jan; 70(1):44-50.
    View PubMed
  10. Chopra A, Tye SJ, Lee KH, Sampson S, Matsumoto J, Adams A, Klassen B, Stead M, Fields JA, Frye MA. Underlying neurobiology and clinical correlates of mania status after subthalamic nucleus deep brain stimulation in Parkinson's disease: a review of the literature. J Neuropsychiatry Clin Neurosci. 2012 Winter; 24(1):102-10.
    View PubMed
  11. Klaas JP, Ahlskog JE, Pittock SJ, Matsumoto JY, Aksamit AJ, Bartleson JD, Kumar R, McEvoy KF, McKeon A. Adult-onset opsoclonus-myoclonus syndrome. Arch Neurol. 2012 Dec; 69(12):1598-607.
    View PubMed
  12. Hassan A, Ahlskog JE, Rodriguez M, Matsumoto JY. Surgical therapy for multiple sclerosis tremor: a 12-year follow-up study. Eur J Neurol. 2012 May; 19(5):764-8. Epub 2012 Jan 17.
    View PubMed
  13. Iodice V, Lipp A, Ahlskog JE, Sandroni P, Fealey RD, Parisi JE, Matsumoto JY, Benarroch EE, Kimpinski K, Singer W, Gehrking TL, Gehrking JA, Sletten DM, Schmeichel AM, Bower JH, Gilman S, Figueroa J, Low PA. Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests. J Neurol Neurosurg Psychiatry. 2012 Apr; 83(4):453-9. Epub 2012 Jan 06.
    View PubMed
  14. McKeon A, Robinson MT, McEvoy KM, Matsumoto JY, Lennon VA, Ahlskog JE, Pittock SJ. Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Arch Neurol. 2012 Feb; 69(2):230-8.
    View PubMed
  15. Savica R, Kumar N, Ahlskog JE, Josephs KA, Matsumoto JY, McKeon A. Parkinsonism and dropped head: dystonia, myopathy or both? Parkinsonism Relat Disord. 2012 Jan; 18(1):30-4. Epub 2011 Aug 27.
    View PubMed
  16. Savica R, Grossardt BR, Bower JH, Klassen BT, Matsumoto JY. Clinical failure of botulinum toxin A in movement disorders. Parkinsonism Relat Disord. 2012 Jan; 18(1):73-5. Epub 2011 Aug 30.
    View PubMed
  17. Savica R, Matsumoto JY, Josephs KA, Ahlskog JE, Stead M, Lee KH, Klassen BT. Deep brain stimulation in benign tremulous parkinsonism. Arch Neurol. 2011 Aug; 68(8):1033-6.
    View PubMed
  18. Czarnecki K, Jones DT, Burnett MS, Mullan B, Matsumoto JY. SPECT perfusion patterns distinguish psychogenic from essential tremor. Parkinsonism Relat Disord. 2011 Jun; 17(5):328-32. Epub 2011 Feb 12.
    View PubMed
  19. Hassan A, Bower JH, Kumar N, Matsumoto JY, Fealey RD, Josephs KA, Ahlskog JE. Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies. Parkinsonism Relat Disord. 2011 May; 17(4):260-4. Epub 2011 Feb 09.
    View PubMed
  20. Schiefer TK, Matsumoto JY, Lee KH. Moving forward: advances in the treatment of movement disorders with deep brain stimulation. Front Integr Neurosci. 2011; 5:69. Epub 2011 Nov 09.
    View PubMed
  21. Hassan A, Bower JH, Kumar N, Matsumoto JY, Fealey RD, Josephs KA, Ahlskog JE. Corrigendum to "Dopamine agonist-triggered pathological behaviors: Surveillance in the PD clinic reveals high frequencies" [Parkinsonism Relat Disord 17 (2011) 260-264]. Parkinsonism Relat Disord. 2011; 17(6):499.
  22. Schiefer TK, Matsumoto J, Lee KH. Moving forward: Advances in the treatment of movement disorders with deep brain stimulation. Frontiers in Integrative Neuroscience. 2010 Nov; 5:69.
  23. Pittock SJ, Parisi JE, McKeon A, Roemer SF, Lucchinetti CF, Tan KM, Keegan BM, Hunter SF, Duncan PR, Baehring JM, Matsumoto JY, Lennon VA. Paraneoplastic jaw dystonia and laryngospasm with antineuronal nuclear autoantibody type 2 (anti-Ri). Arch Neurol. 2010 Sep; 67(9):1109-15.
    View PubMed
  24. Diaz GE, Wirrell EC, Matsumoto JY, Krecke KN. Bilateral striopallidodentate calcinosis with paroxysmal kinesigenic dyskinesia. Pediatr Neurol. 2010 Jul; 43(1):46-8.
    View PubMed
  25. McKeon A, Ahlskog JE, Bower JH, Josephs KA, Matsumoto JY. Psychogenic tremor: long-term prognosis in patients with electrophysiologically confirmed disease. Mov Disord. 2009 Jan 15; 24(1):72-6.
    View PubMed
  26. McKeon A, Matsumoto JY, Bower JH, Ahlskog JE. The spectrum of disorders presenting as adult-onset focal lower extremity dystonia. Parkinsonism Relat Disord. 2008 Dec; 14(8):613-9. Epub 2008 Mar 07.
    View PubMed
  27. McKeon A, Ahlskog JE, Matsumoto JY. Psychogenic tremor occurring after deep brain stimulation surgery for essential tremor. Neurology. 2008 Apr 15; 70(16 Pt 2):1498-9.
    View PubMed
  28. Glass GA, Ahlskog JE, Matsumoto JY. Orthostatic myoclonus: a contributor to gait decline in selected elderly. Neurology. 2007 May 22; 68(21):1826-30. Epub 2007 Mar 14.
    View PubMed
  29. Elble RJ, Pullman SL, Matsumoto JY, Raethjen J, Deuschl G, Tintner R, Tremor Research Group. Tremor amplitude is logarithmically related to 4- and 5-point tremor rating scales. Brain. 2006 Oct; 129(Pt 10):2660-6. Epub 2006 Aug 03.
    View PubMed
  30. Josephs KA, Matsumoto JY, Ahlskog JE. Benign tremulous parkinsonism. Arch Neurol. 2006 Mar; 63(3):354-7.
    View PubMed
  31. Klos KJ, Bower JH, Josephs KA, Matsumoto JY, Ahlskog JE. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord. 2005 Sep; 11(6):381-6.
    View PubMed
  32. Josephs KA, Uchikado H, McComb RD, Bashir R, Wszolek Z, Swanson J, Matsumoto J, Shaw G, Dickson DW. Extending the clinicopathological spectrum of neurofilament inclusion disease. Acta Neuropathol (Berl) 2005 Apr; 109(4):427-32.
    View PubMed
  33. Josephs KA, Matsumoto JY, Lindor NM. Heterozygous Niemann-Pick disease type C presenting with tremor. Neurology. 2004 Dec 14; 63(11):2189-90.
    View PubMed
  34. Pittock SJ, McClelland RL, Mayr WT, Rodriguez M, Matsumoto JY. Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted County population. Mov Disord. 2004 Dec; 19(12):1482-5.
    View PubMed
  35. Gabriel DA, Matsumoto JY, Davis DH, Currier BL, An KN. Multidirectional neck strength and electromyographic activity for normal controls. Clin Biomech. 2004 Aug; 19(7):653-8.
    View PubMed
  36. Hardesty DE, Maraganore DM, Matsumoto JY, Louis ED. Increased risk of head tremor in women with essential tremor: Longitudinal data from the Rochester epidemiology project. Mov Disord. 2004 May; 19(5):529-33.
    View PubMed
  37. Mokri B, Ahlskog JE, Fulgham JR, Matsumoto JY. Syndrome resembling PSP after surgical repair of ascending aorta dissection or aneurysm. Neurology. 2004 Mar 23; 62(6):971-3.
    View PubMed
  38. Boeve BF, Silber MH, Parisi JE, Dickson DW, Ferman TJ, Benarroch EE, Schmeichel AM, Smith GE, Petersen RC, Ahlskog JE, Matsumoto JY, Knopman DS, Schenck CH, Mahowald MW. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology. 2003 Jul 8; 61(1):40-5.
    View PubMed
  39. Cohen-Gadol AA, Ahlskog JE, Matsumoto JY, Swenson MA, McClelland RL, Davis DH. Selective peripheral denervation for the treatment of intractable spasmodic torticollis: experience with 168 patients at the Mayo Clinic. J Neurosurg. 2003 Jun; 98(6):1247-54.
    View PubMed
  40. Matsumoto J, Morrow D, Kaufman K, Davis D, Ahlskog JE, Walker A, Sneve D, Noseworthy J, Rodriguez M. Surgical therapy for tremor in multiple sclerosis: an evaluation of outcome measures. Neurology. 2001 Nov 27; 57(10):1876-82.
    View PubMed
  41. Brin MF, Lyons KE, Doucette J, Adler CH, Caviness JN, Comella CL, Dubinsky RM, Friedman JH, Manyam BV, Matsumoto JY, Pullman SL, Rajput AH, Sethi KD, Tanner C, Koller WC. A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor. Neurology. 2001 Jun 12; 56(11):1523-8.
    View PubMed
  42. Van Gerpen JA, Matsumoto JY, Ahlskog JE, Maraganore DM, McManis PG. Utility of an EMG mapping study in treating cervical dystonia. Muscle Nerve. 2000 Nov; 23(11):1752-6.
    View PubMed
  43. Keegan MT, Flick RP, Matsumoto JY, Davis DH, Lanier WL. Anesthetic management for two-stage computer-assisted, stereotactic thalamotomy in a child with Hallervorden-Spatz Disease. J Neurosurg Anesthesiol. 2000 Apr; 12(2):107-11.
    View PubMed
  44. Ahlskog JE, Uitti RJ, O'Connor MK, Maraganore DM, Matsumoto JY, Stark KF, Turk MF, Burnett OL. The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease. Mov Disord. 1999 Nov; 14(6):940-6.
    View PubMed
  45. Rubin DI, Matsumoto JY, Suarez GA, Auger RG. Facial trigeminal synkinesis associated with a trigeminal schwannoma. Neurology. 1999 Aug 11; 53(3):635-7.
    View PubMed
  46. O'Suilleabhain PE, Lagerlund TD, Matsumoto JY. Cortical potentials at the frequency of absolute wrist velocity become phase-locked during slow sinusoidal tracking movements. Exp Brain Res. 1999 Jun; 126(4):529-35.
    View PubMed
  47. Matsumoto JY, Dodick DW, Stevens LN, Newman RC, Caskey PE, Fjerstad W. Three-dimensional measurement of essential tremor. Mov Disord. 1999 Mar; 14(2):288-94.
    View PubMed
  48. Warner MA, Warner DO, Matsumoto JY, Harper CM, Schroeder DR, Maxson PM. Ulnar neuropathy in surgical patients. Anesthesiology. 1999 Jan; 90(1):54-9.
    View PubMed
  49. O'Suilleabhain PE, Matsumoto JY. Time-frequency analysis of tremors. Brain. 1998 Nov; 121(Pt 11):2127-34.
    View PubMed
  50. Dewey RB Jr, Maraganore DM, Ahlskog JE, Matsumoto JY. A double-blind, placebo-controlled study of intranasal apomorphine spray as a rescue agent for off-states in Parkinson's disease. Mov Disord. 1998 Sep; 13(5):782-7.
    View PubMed
  51. Dewey RB Jr, Maraganore DM, Ahlskog JE, Matsumoto JY. Intranasal apomorphine rescue therapy for parkinsonian "off" periods. Clin Neuropharmacol. 1996 Jun; 19(3):193-201.
    View PubMed
  52. Silbert PL, Matsumoto JY, McManis PG, Stolp-Smith KA, Elliott BA, McEvoy KM. Intrathecal baclofen therapy in stiff-man syndrome: a double-blind, placebo-controlled trial. Neurology. 1995 Oct; 45(10):1893-7.
    View PubMed
  53. Deuschl G, Toro C, Matsumoto JY, Hallett M. Movement-Related Cortical Potentials in Writer's Cramp. Annals of Neurology. 1995; 38:862-8.
    View PubMed
  54. Ahlskog JE, Muenter MD, Maraganore DM, Matsumoto JY, Lieberman A, Wright KF, Wheeler K. Fluctuating Parkinson's disease. Treatment with the long-acting dopamine agonist cabergoline. Arch Neurol. 1994 Dec; 51(12):1236-41.
    View PubMed
  55. Matsumoto JY, Caviness JN, McEvoy KM. The acoustic startle reflex in stiff-man syndrome. Neurology. 1994 Oct; 44(10):1952-5.
    View PubMed
  56. Dewey RB Jr, Maraganore DM, Matsumoto JY. Posttraumatic cervical dystonia manifesting as isolated spasm of the middle scalene muscle. Mayo Clin Proc. 1994 Feb; 69(2):187-8.
    View PubMed
  57. Lieberman A, Imke S, Muenter M, Wheeler K, Ahlskog JE, Matsumoto JY, Maraganore DM, Wright KF, Schoenfelder J. Multicenter study of cabergoline, a long-acting dopamine receptor agonist, in Parkinson's disease patients with fluctuating responses to levodopa/carbidopa. Neurology. 1993 Oct; 43(10):1981-4.
    View PubMed
  58. Basford JR, Hallman HO, Matsumoto JY, Moyer SK, Buss JM, Baxter GD. Effects of 830 nm continuous wave laser diode irradiation on median nerve function in normal subjects. Lasers in Surgery & Medicine. 1993; 13(6):597-604.
    View PubMed
  59. Toro C, Matsumoto JY, Deuschl G, Roth BJ, Hallett M. Source Analysis of Scalp-Recorded Movement-Related Electrical Potentials. Electroencephalography and Clinical Neurophysiology. 1993; 86:167-75.
    View PubMed
  60. Matsumoto J, Fuhr P, Nigro M, Hallett M. Physiological abnormalities in hereditary hyperekplexia. Ann Neurol. 1992 Jul; 32(1):41-50.
    View PubMed
  61. Matsumoto JY, O'Neill BP, Piepgras DG, Scheithauer B. Metastatic malignant glioma with resultant extradural compression of a sacral nerve root. J Neurooncol. 1987; 4(3):227-31.
    View PubMed
  62. Howard FM, Lennon VA, Finely J, Matsumoto JY, Elveback LR. Correlations of Antibodies that Bind, Block, or Modulate Human Acetylcholine Receptors in Myasthenia Gravis. Ann NY Academy of Sci. 1986.
  63. Indrelie JA, Wilson WR, Matsumoto JY, Geraci JE, Washington JA 2nd. Synergy of imipenem or penicillin G and aminoglycosides against enterococci isolated from patients with infective endocarditis. Antimicrobial Agents & Chemotherapy. 1984 Dec; 26(6):909-12.
    View PubMed
  64. Wright AJ, Wilson WR, Matsumoto JY, Washington JA 2nd, Geraci JE. Influence of gentamicin dose size on the efficacies of combinations of gentamicin and penicillin in experimental streptomycin-resistant enterococcal endocarditis. Antimicrobial Agents & Chemotherapy. 1982 Dec; 22(6):972-5.
    View PubMed
  65. Matsumoto JY, Wilson WR, Wright AJ, Geraci JE, Washington JA II. Synergy of penicillin and decreasing concentrations of aminoglycosides against enterococci from patients with infective endocarditis. Antimicrob Agents Chemother. 1980 Dec; 18:944-947.
    View PubMed